GB0230202D0 - Ligand - Google Patents

Ligand

Info

Publication number
GB0230202D0
GB0230202D0 GB0230202A GB0230202A GB0230202D0 GB 0230202 D0 GB0230202 D0 GB 0230202D0 GB 0230202 A GB0230202 A GB 0230202A GB 0230202 A GB0230202 A GB 0230202A GB 0230202 D0 GB0230202 D0 GB 0230202D0
Authority
GB
United Kingdom
Prior art keywords
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0230202A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Domantis Ltd
Original Assignee
Domantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Domantis Ltd filed Critical Domantis Ltd
Priority to GB0230202A priority Critical patent/GB0230202D0/en
Publication of GB0230202D0 publication Critical patent/GB0230202D0/en
Priority to PCT/GB2003/002804 priority patent/WO2004003019A2/en
Priority to EP03738294A priority patent/EP1517921B1/en
Priority to PT03738294T priority patent/PT1517921E/en
Priority to JP2004516979A priority patent/JP2006512895A/en
Priority to DE60305919T priority patent/DE60305919T2/en
Priority to EP09158112A priority patent/EP2135879A3/en
Priority to CNA038204584A priority patent/CN1678634A/en
Priority to ES03738294T priority patent/ES2263984T3/en
Priority to SI200330414T priority patent/SI1517921T1/en
Priority to DK03738294T priority patent/DK1517921T3/en
Priority to EP10179045A priority patent/EP2366718A3/en
Priority to AT03738294T priority patent/ATE328906T1/en
Priority to CA002492092A priority patent/CA2492092A1/en
Priority to AU2003244817A priority patent/AU2003244817B2/en
Priority to EP05076402A priority patent/EP1600459A3/en
Priority to JP2005509717A priority patent/JP2006523090A/en
Priority to CA002511910A priority patent/CA2511910A1/en
Priority to AU2003290330A priority patent/AU2003290330A1/en
Priority to EP03782689A priority patent/EP1578801A2/en
Priority to PCT/GB2003/005646 priority patent/WO2004058821A2/en
Priority to CN 200380109315 priority patent/CN1745102A/en
Priority to US10/925,366 priority patent/US20050271663A1/en
Priority to US10/985,847 priority patent/US20060002935A1/en
Priority to US11/023,959 priority patent/US20060106203A1/en
Priority to HK05103582A priority patent/HK1070081A1/en
Priority to GBGB0501752.0A priority patent/GB0501752D0/en
Priority to US11/098,758 priority patent/US20060073141A1/en
Priority to US11/141,661 priority patent/US20060257406A1/en
Priority to US11/217,919 priority patent/US20060063921A1/en
Priority to US11/664,542 priority patent/US20080008713A1/en
Priority to MX2007005650A priority patent/MX2007005650A/en
Priority to US11/667,393 priority patent/US20070298041A1/en
Priority to US11/338,863 priority patent/US20070104710A1/en
Priority to US11/501,522 priority patent/US20070093651A1/en
Priority to US11/501,546 priority patent/US20100234570A1/en
Priority to CY20061101247T priority patent/CY1105191T1/en
Priority to ZA200610474A priority patent/ZA200610474B/en
Priority to US11/704,832 priority patent/US9321832B2/en
Priority to IL183027A priority patent/IL183027A0/en
Priority to ZA200703755A priority patent/ZA200703755B/en
Priority to US11/981,821 priority patent/US20100081792A1/en
Priority to US12/006,933 priority patent/US20080241166A1/en
Priority to US12/150,567 priority patent/US20080233130A1/en
Priority to US12/150,487 priority patent/US20080233129A1/en
Priority to US12/409,617 priority patent/US20090258012A1/en
Priority to JP2011005778A priority patent/JP2011125342A/en
Priority to US13/111,516 priority patent/US20110223168A1/en
Priority to US13/181,834 priority patent/US9028822B2/en
Priority to US13/733,675 priority patent/US20130216538A1/en
Priority to US14/173,204 priority patent/US20150087813A1/en
Priority to US14/924,971 priority patent/US20170145080A1/en
Ceased legal-status Critical Current

Links

GB0230202A 2001-06-28 2002-12-27 Ligand Ceased GB0230202D0 (en)

Priority Applications (52)

Application Number Priority Date Filing Date Title
GB0230202A GB0230202D0 (en) 2002-12-27 2002-12-27 Ligand
PCT/GB2003/002804 WO2004003019A2 (en) 2002-06-28 2003-06-30 Immunoglobin single variant antigen-binding domains and dual-specific constructs
EP03738294A EP1517921B1 (en) 2002-06-28 2003-06-30 Dual specific ligands with increased serum half-life
PT03738294T PT1517921E (en) 2002-06-28 2003-06-30 DIFFERENTLY SPECIFIED LIGANDS WITH SEMI-LIFE IN THE INCREASED SERUM
JP2004516979A JP2006512895A (en) 2002-06-28 2003-06-30 Ligand
DE60305919T DE60305919T2 (en) 2002-06-28 2003-06-30 DUAL SPECIFIC LIGANDS WITH INCREASED HALF TIME
EP09158112A EP2135879A3 (en) 2002-06-28 2003-06-30 Ligand
CNA038204584A CN1678634A (en) 2002-06-28 2003-06-30 Immunoglobulin single variable antigen combination area and its opposite constituent
ES03738294T ES2263984T3 (en) 2002-06-28 2003-06-30 DOUBLE-SPECIFIC LINKS WITH AN INCREASED SERIOUS MIDDLE LIFE.
SI200330414T SI1517921T1 (en) 2002-06-28 2003-06-30 Dual specific ligands with increased serum half-life
DK03738294T DK1517921T3 (en) 2002-06-28 2003-06-30 Immunoglobulin single variable antigen binding domains and double specific constructs thereof
EP10179045A EP2366718A3 (en) 2002-06-28 2003-06-30 Ligand
AT03738294T ATE328906T1 (en) 2002-06-28 2003-06-30 DUAL-SPECIFIC LIGANDS WITH INCREASED HALF-LIFE
CA002492092A CA2492092A1 (en) 2002-06-28 2003-06-30 Immunoglobin single variant antigen-binding domains and dual-specific constructs
AU2003244817A AU2003244817B2 (en) 2002-06-28 2003-06-30 Antigen-binding immunoglobulin single variable domains and dual-specific constructs
EP05076402A EP1600459A3 (en) 2002-06-28 2003-06-30 Ligand
JP2005509717A JP2006523090A (en) 2002-12-27 2003-12-24 Bispecific single domain antibody specific for ligand and for ligand receptor
CA002511910A CA2511910A1 (en) 2002-12-27 2003-12-24 Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
AU2003290330A AU2003290330A1 (en) 2002-12-27 2003-12-24 Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
EP03782689A EP1578801A2 (en) 2002-12-27 2003-12-24 Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
PCT/GB2003/005646 WO2004058821A2 (en) 2002-12-27 2003-12-24 Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
CN 200380109315 CN1745102A (en) 2002-12-27 2003-12-24 Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
US10/925,366 US20050271663A1 (en) 2001-06-28 2004-08-24 Compositions and methods for treating inflammatory disorders
US10/985,847 US20060002935A1 (en) 2002-06-28 2004-11-10 Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
US11/023,959 US20060106203A1 (en) 2002-06-28 2004-12-28 Ligand
HK05103582A HK1070081A1 (en) 2002-06-28 2005-01-01 Dual specific ligands with increased serum half-life
GBGB0501752.0A GB0501752D0 (en) 2002-06-28 2005-01-27 Immunoglobin single variant antigen-binding domains and dual-specific constructs
US11/098,758 US20060073141A1 (en) 2001-06-28 2005-04-04 Compositions and methods for treating inflammatory disorders
US11/141,661 US20060257406A1 (en) 2002-12-27 2005-05-31 Ligand
US11/217,919 US20060063921A1 (en) 2002-06-28 2005-09-01 Ligand
US11/664,542 US20080008713A1 (en) 2002-06-28 2005-10-07 Single domain antibodies against tnfr1 and methods of use therefor
MX2007005650A MX2007005650A (en) 2002-12-27 2005-11-10 Ligands that enhance endogenous compounds.
US11/667,393 US20070298041A1 (en) 2002-06-28 2005-11-10 Ligands That Enhance Endogenous Compounds
US11/338,863 US20070104710A1 (en) 2002-06-28 2006-01-24 Ligand that has binding specificity for IL-4 and/or IL-13
US11/501,522 US20070093651A1 (en) 2001-06-28 2006-08-08 Ligand
US11/501,546 US20100234570A1 (en) 2001-06-28 2006-08-08 Ligand
CY20061101247T CY1105191T1 (en) 2002-06-28 2006-09-04 DUAL SPECIFICATION CONNECTORS WITH INCREASED HALF-LIFE
ZA200610474A ZA200610474B (en) 2002-12-27 2006-12-13 Compositions and methods for treating inflammatory disorders
US11/704,832 US9321832B2 (en) 2002-06-28 2007-02-08 Ligand
IL183027A IL183027A0 (en) 2002-06-28 2007-05-07 Ligands that enhance endogenous compounds
ZA200703755A ZA200703755B (en) 2002-12-27 2007-05-09 Ligands that enhance endogenous compounds
US11/981,821 US20100081792A1 (en) 2001-06-28 2007-10-31 Ligand
US12/006,933 US20080241166A1 (en) 2002-06-28 2008-01-07 Ligands that bind a receptor
US12/150,567 US20080233130A1 (en) 2002-06-28 2008-04-29 Ligand that has binding specificity for IL-4 and/or IL-13
US12/150,487 US20080233129A1 (en) 2002-06-28 2008-04-29 Ligand that has binding specificity for IL-4 and/or lL-13
US12/409,617 US20090258012A1 (en) 2001-06-28 2009-03-24 Compositions and methods for treating inflammatory disorders
JP2011005778A JP2011125342A (en) 2002-06-28 2011-01-14 Ligand
US13/111,516 US20110223168A1 (en) 2002-12-27 2011-05-19 Ligand that has binding specificity for il-4 and/or il-13
US13/181,834 US9028822B2 (en) 2002-06-28 2011-07-13 Antagonists against TNFR1 and methods of use therefor
US13/733,675 US20130216538A1 (en) 2002-12-27 2013-01-03 Compositions and Methods for Treating Inflammatory Disorders
US14/173,204 US20150087813A1 (en) 2001-06-28 2014-02-05 Ligand
US14/924,971 US20170145080A1 (en) 2002-12-27 2015-10-28 Ligand

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0230202A GB0230202D0 (en) 2002-12-27 2002-12-27 Ligand

Publications (1)

Publication Number Publication Date
GB0230202D0 true GB0230202D0 (en) 2003-02-05

Family

ID=9950454

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0230202A Ceased GB0230202D0 (en) 2001-06-28 2002-12-27 Ligand

Country Status (3)

Country Link
CN (1) CN1745102A (en)
GB (1) GB0230202D0 (en)
ZA (1) ZA200610474B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014144573A2 (en) * 2013-03-15 2014-09-18 Memorial Sloan-Kettering Cancer Center Multimerization technologies
WO2016097313A1 (en) * 2014-12-19 2016-06-23 Ablynx N.V. Cysteine linked nanobody dimers
SG11201807176XA (en) 2016-03-11 2018-09-27 Scholar Rock Inc TGFß1-BINDING IMMUNOGLOBULINS AND USE THEREOF
AU2018205231A1 (en) * 2017-01-06 2019-07-18 Scholar Rock, Inc. Isoform-specific, context-permissive TGFβ1 inhibitors and use thereof
CN111701580B (en) * 2019-12-26 2022-02-15 华中科技大学 Middle molecular toxin adsorbent for removing beta 2 microglobulin in blood

Also Published As

Publication number Publication date
ZA200610474B (en) 2009-09-30
CN1745102A (en) 2006-03-08

Similar Documents

Publication Publication Date Title
DE50311874D1 (en) Spirocyclische cyclohexan-derivate
IL174020A0 (en) Antigen-scaffold complexes
AU2003297193A8 (en) Meta-web
DE50309217D1 (en) Benzimidazolderivate
AU2003272511A8 (en) Cd44-binding ligands
AU2003279495A8 (en) Alert-modeling
DE50308027D1 (en) Cyclohexyl-harnstoff-derivate
DE50303619D1 (en) Reibschweissvorrichtung
DE50307787D1 (en) Isophthalsäurederivate
DE50312412D1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamin-derivative
DE50311133D1 (en) Carbonsäureamide
GB0226374D0 (en) Ligands
DE50310169D1 (en) Lingual-retainer
AU2003264900A8 (en) Cast-cutter
DE50304964D1 (en) Handhobelmaschine
IL174218A0 (en) Ligands
GB0230202D0 (en) Ligand
AU2003262681A8 (en) Hemo-aide
DE10392833D2 (en) Geotextilie
GB0115841D0 (en) Ligand
AU2003216512A8 (en) Integrin ligand
AU2002341221A8 (en) Honey-brandy
AU2003253735A8 (en) Vacuolins
GB0313709D0 (en) Ligands
DE50309021D1 (en) Etherlacton

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)